HCWB
NASD HCW Biologics, Inc.$1.68 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.68, $0.04 below the day’s high of $1.72
- YTD change
- -71.15%
- vs 20-day SMA
- -19.62%
- vs 200-day SMA
- -65.27%
Price ranges
Price & Performance
+1.39 (+484.55%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.9% away from all-time highs of $1,866.00
- HCWB is down 71% since the beginning of the year
- HCWB is down 92% over the past 12 months
- HCWB is down 50% over the past 1 month
- 0% of all HCWB investors are betting against HCWB
HCWB reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -58.4%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -15.58%
- vs 8-day SMA
- -6.41%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
